Published on
October 30, 2017
- 00:00 GMT
INSYS Therapeutics Affirms Its Commitment to Sustainable Future Growth
PHOENIX, Oct. 29, 2017 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ:INSY) (“INSYS” or “the company”), today released the following statement from its president and chief executive officer, Saeed Motahari: “While we are saddened by the events of the …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
